Citigroup Inc. trimmed its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 90.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,453 shares of the biotechnology company's stock after selling 746,247 shares during the quarter. Citigroup Inc. owned about 0.11% of Axon Enterprise worth $32,149,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Massachusetts Financial Services Co. MA acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $120,553,000. King Luther Capital Management Corp increased its stake in shares of Axon Enterprise by 0.3% in the 3rd quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company's stock worth $4,185,000 after acquiring an additional 34 shares during the last quarter. Advisors Asset Management Inc. raised its holdings in shares of Axon Enterprise by 2.9% during the 3rd quarter. Advisors Asset Management Inc. now owns 30,442 shares of the biotechnology company's stock worth $12,165,000 after acquiring an additional 850 shares during the period. Jennison Associates LLC boosted its position in shares of Axon Enterprise by 48.2% during the 3rd quarter. Jennison Associates LLC now owns 3,977 shares of the biotechnology company's stock valued at $1,589,000 after acquiring an additional 1,294 shares during the last quarter. Finally, Avior Wealth Management LLC increased its position in Axon Enterprise by 3.0% during the third quarter. Avior Wealth Management LLC now owns 2,995 shares of the biotechnology company's stock worth $1,197,000 after purchasing an additional 86 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.
AXON has been the topic of several recent analyst reports. Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Craig Hallum increased their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a "buy" rating in a research report on Wednesday, August 7th. JMP Securities lifted their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research report on Thursday, October 31st. The Goldman Sachs Group increased their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a report on Wednesday, October 23rd. Finally, Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an "outperform" rating in a report on Monday, November 11th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and an average price target of $427.83.
Check Out Our Latest Research Report on Axon Enterprise
Shares of AXON stock opened at $619.00 on Tuesday. The firm has a 50 day moving average of $468.24 and a two-hundred day moving average of $370.65. The stock has a market capitalization of $47.20 billion, a PE ratio of 159.95, a P/E/G ratio of 14.02 and a beta of 0.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52 week low of $224.28 and a 52 week high of $641.20.
In other news, insider Jeffrey C. Kunins sold 21,834 shares of the firm's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua Isner sold 20,000 shares of the business's stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now owns 208,166 shares of the company's stock, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 260,256 shares of company stock worth $105,984,120. Company insiders own 5.70% of the company's stock.
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.